MedTrace Logo

Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression

NCT00903448 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-12-31

Study results available
· View outcomes & findings →

Summary

The objective of this study is to compare Prilosec OTC® to Prevacid® for gastric acid suppression.

Conditions

  • Healthy

Interventions

DRUG

Prilosec OTC (omeprazole-magnesium)

Prilosec OTC (omeprazole-magnesium 20.6 mg) tablet to be taken with a glass of water prior to breakfast

DRUG

Prevacid

Prevacid (15 mg lansoprazole) capsule to be taken with a glass of water prior to breakfast

Sponsors & Collaborators

  • Procter and Gamble

    lead INDUSTRY

Principal Investigators

  • Simon H Magowan, MD · Procter and Gamble

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00903448 on ClinicalTrials.gov